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Abstract
Caffeine is the most widely consumed psychoactive drug, with the prevalence of
use approaching 80% of the world's population. In stark contrast to most stimulants,
caffeine is considered an innocuous agent with advantageous behavioral effects.
Nonetheless, the sustained use of caffeine can result in tolerance or sensitization to the
pharmacologic and behavioral effects of the drug effects shared with other stimulants
including amphetamine and cocaine. Moreover, unlike cocaine, caffeine abstinence
results in unique withdrawal symptoms that are easily identified. The observation of
withdrawal, dependence, and tolerance, notions usually associated with drug abuse,
suggest caffeine consumption may provide an intriguing model of substance abuse. To
this end, the aims of this work were to delineate environmental factors that establish
caffeine self-administration in rats. The self-administration of caffeine was established
and modified by a combination of behavioral and pharmacological factors including food
restriction, drug dose, and infusion rate. The results suggest caffeine-maintained behavior
is comparable to nicotine self-administration, but distinct from that of cocaine or heroin.
These findings highlight the role of non-pharmacological factors in substance abuse and
suggest that further investigations evaluating the reinforcing effects of caffeine can
enhance the understanding and treatment of drug abuse.
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Caffeine Self-Administration
INTRODUCTION
Persistent behavior maintained by access to and consumption of a substance is a
hallmark of substance abuse. Termed an operant by behavioral psychologists, substance
abuse, similar to behavior maintained by other environmental events, is maintained by the
response-dependent delivery of a drug. A malleable response, the characteristics of which
are dependent on environmental fluctuations, operants may be empirically analyzed,
parsing out the permutation of controlling variables. Behavior maintained by the delivery
of a drug is also subject to the same functional analysis as responses maintained by non-
drug reinforcers.
Assessing the determinants of reinforcement involves evaluating several classes
of variables in order to specify the environmental elements controlling behavior.
Requisites in understanding this process begin with evaluating the behavioral history of
the subject and subsequently examining the specific combination of events occasioning
the operant. Inferences involving the efficacy of a reinforcer may be drawn from specific
elements of behavior, including rates and temporal patterns of response and resistance to
change (Nevin, 1974). Although of great merit, significant problems emerge when
evaluating reinforcing effects using these measures, a discussion which is beyond the
scope of this paper. However, when the reinforcing event is a pharmacologic compound,
the model allowing for the most direct assessment of variables involved in engendering
and maintaining drug seeking, including relative reinforcing effects, is the animal self-
administration paradigm.   
Since its inception, empirical analyses of the self-administration paradigm have
identified and clarified variables controlling drug maintained responding,  The
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information garnered from these analyses have delineated drugs which have high abuse
liability, the specific neurochemistry which maintains responding, and many of the
behavioral parameters which regulate drug intake. Moreover, rodent drug self-
administration studies demonstrate these effects efficiently, with conservation of time and
funds, situating the model as indispensable in drug development and research.
Importantly, the model aligns with the current understanding of the phenomena while
directing research to the imperative remaining questions (Massoud, Hademenos, Young,
Goa, Pile-Spellman & Vinuela, 1998).
Animal Self-Administration as a Model of Drug Use
To better understand the phenomena associated with drug use in human beings, it
is necessary to have an experimental analog which allows for the examination of specific
aspects of behavior.  An appropriate animal model should be consistent and reliable, with
high degrees of control.  Moreover, a model should have predictive utility, elucidating
properties of behavior in a valid manner (Koob, 1995).
The animal self-administration model, namely the rodent model, has proven to be
a very useful tool in the investigation of drug abuse.  Over a series of studies, it has been
established that drugs which are readily self-administered by rodents closely approximate
the drugs which pose problems for human beings. Based upon this consistent correlation,
the animal self-administration model has been indispensable in identifying abuse liability
effects in new compounds. Used in pre-clinical trials, agents are tested to determine if the
presentation of the novel drug will maintain self-administration. If the drug maintains
self-administration, it may have abuse potential (Johanson & Balster, 1978; Koob, 1995). 
Also within the scope of the model is the identification of the particular
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neurochemical effects coinciding with drug consumption. Clarifying the translation
between biological effects and behavioral effects, the observation of specific neuronal
states during self-administration enhances the understanding of the biological
underpinnings associated with drug consumption behavior.
Specifically, the rodent self-administration model has provided an experimental
setting that elucidates some of the factors potentiating the reinstatement of drug
consumption. The model contends that after self-administration of a drug is established
and subsequently maintained, the operant is interrupted, whereby the previously
reinforced response no longer produces drug presentation. Criterion for extinction are
relatively arbitrary, but a common designation is that percentage of responding in the last
extinction session must be a relatively low percentage of the behavior observed in the
first extinction session.  After sufficient exposure to the extinction contingency, animals
will eventually cease engaging in the operant and the behavior is considered
extinguished. This situation provides ideal experimental setting to examine the factors
which set the occasion for the regeneration of responding.
Relapse, the initiation of drug use after a period of abstinence, is a prominent
issue in drug rehabilitation.  Understanding the mechanisms which potentiate this
behavior will undoubtedly lead to better clinical treatment programs and aid in the
development of effective prevention programs.
Through decisive publications concerning reinstatement of animal drug self-
administration, it has been demonstrated that previously extinguished drug-maintained
responding may be reinstated via three distinct stimulus presentations.  Upon the
termination of drug-maintained responding, the presentation of stimuli previously paired
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with the drug precipitates responding (McFarland & Ettenburg, 1997; de Wit & Stewart,
1981).  Discrete cues once paired with the drug or discriminative cues signaling drug
availability have induced drug-seeking behavior.  Speaking to both respondent
conditioning effects as well as the stimulus control of an operant, these results indicate
reinstatement behavior is sensitive to the permutation of environmental parameters
present.
Moreover, response independent presentations of the previously self-administered
compound engender the diminished operant as well.  Cocaine, heroin and amphetamine
self-administration are all reinstated through priming injections of the self-administered
drug (Stretch et al., 1971; Davis & Smith, 1976; de wit & Stewart, 1981; 1983).
Although few studies have been conducted using human subjects, there is evidence that
this model of reinstatement has clinical applicability.  When cocaine users are exposed to
a series of choice trials between money and an i.v. infusion of cocaine, a priming dose of
cocaine prior to the choice trials shifts preference toward cocaine choices earlier in the
session (as compared to placebo) (Donny, Bigelow & Walsh, 2004).   Moreover, drug
liking reports increase prior to cocaine self-administration sessions when a priming dose
of cocaine is administered (Walsh, Haberny & Bigelow, 2000).    Thus, there is evidence
that this model may also provide invaluable information in the development of
pharmacotherapeutics to abate drug relapse.
In addition, high levels of stress may also re-initiate drug seeking.  After cocaine
or heroin self-administration responses are effectually extinguished, intermittent
footshock presentations (0.5 to 1.0 mA) reliably reinstate “drug-seeking” behavior (Erb,
Shaham & Stewart, 1996).  This effect has been reported across various conditions,
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including a 6-week drug-free phase, various training drugs (heroin cocaine, nicotine and
alcohol) various drug training doses, strains of rats, footshock durations and intensities
(Shaham, Erb & Stewart, 2000).  However, presentation of conditioned stimuli or
discriminative stimuli (paired with footshock or signaled its delivery) failed to reinstate
self-administration behavior (Shaham et al., 2000).
When viewed in summation, the self-administration paradigm has provided a
platform for uncovering the behavioral and neurochemical variables involved in drug
initiation, maintenance and relapse.  With continuing research, prevention methods may
likely develop, along with effective pharmacotherapeutics, to help further understanding
of drug abuse while simultaneously combating it.
Overview of Animal Self-Administration Research
At its inception, self-administration experimentation was primarily an evaluation
of drug dependence, whereby behavior was initially maintained by attenuation of
withdrawal symptoms. Pioneering work by Weeks (1962) reported sustained self-
administration behavior in rats dependent on morphine. Specifically, female rats were
given chronic i.p. injections of in a series of progressively larger doses of morphine.
Doses  were presented in an escalating manner, with the range of doses being  2 mg/kg
to 40 mg/kg, totaling 122 injections. Subsequently, animals were placed in an operant
chamber whereby depression of a lever resulted in an intravenous infusion of morphine,
via a cannula implanted inside the right jugular vein. This model, in the absence of
experimenter interference, allowed animals to allocate drug consumption during the
experimental sessions. Consequently, rates of self-administration were dependent on the
interaction between the ratio requirement (FR 1, FR 5 or FR 10) and the dose of
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morphine available for IV infusion during the session (3.2 mg/kg or 10mg/kg). However,
rates of behavior peaked when animals were in the state of withdrawal, induced by either
an i.p. nalorphine injection or via extinction (lever presses resulting in no scheduled
consequence). Specifically, this behavioral perseveration is often conjectured to be a
model of drug seeking, with the establishing operation being withdrawal symptoms
(surmised as drug craving) and the operant being maintained by negative reinforcement
(the attenuation of physical symptoms).
Physical dependence, although increasing both the rapidity of which the self-
administration operant is acquired, is by no means a prerequisite for engendering drug
self-administration. Predicating an assessment of drugs that would commence and
maintain self-administration, new studies began shifting focus in order to identify drugs
readily self-administered by drug-naïve animals.
With few exceptions, drugs that maintain animal self-administration very closely
align with those that pose problems for humans, stressing the model’s utility as a
predictive measure (Yokel & Pickens, 1973; Weeks & Collins, 1987; Yanagita &
Takahashi, 1982). Incorporating subjects from various species, many early studies have
examined  numerous psychoactive compounds to determine if the agents were able  to
maintain self-administration, providing information about the abuse liability of the drugs
(van Ree et al., 1978; Collins et al., 1984; Yokel, 1987).
 A drug that initiates and maintains self-administration is generally considered to
have reinforcing effects. However, the apparent self-administration of a drug can stem
from other effects not directly related to reinforcing actions. Substantiating that drug
presentation is the event maintaining behavior, an essential measure is to ensure that
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responding eventually cease when the operant does not produce a drug infusion.  When
vehicle is substituted for the drug under examination, there should be an eventual,
marked decrease in the response (Meisch, 1987; Yokel, 1987).
Further evidence that drug presentations are maintaining the operant can be
provided when measuring the allocation of responses between an active manipulandum
and an inactive device.  The active manipulandum, a response on which produces drug
infusion, should engender proportionally greater rates of response than the inactive
device (behavior upon which carries no scheduled consequence) (Pickens & Thompson,
1968; Meisch, 1987; Katz, 1989). However, this measure must be employed cautiously.
Misinterpretations of these data may occur if the doses of the agent under examination
acts as central nervous system stimulant. General locomotor activity may increase,
producing increased responding on the inactive lever, due to the direct effects of the
agent, (with direct effects referring to the drug’s effect on the central nervous system and
the physiological effects that ensue). These direct effects may modify behavior
independent of the indirect effects, with responding on either lever being artificially
increased, due to the effects of the drug under analyzation.  The indirect effects (also
termed reinforcing effects) of the drug may be difficult to interpret due to this effect.
Therefore, additional control methods are necessary to determine the underpinnings of
the behavioral maintenance.
Random alternations of the active device with the inactive, within or between
experimental sessions, ought to produce “tracking” of the lever or key associated with
drug infusions (Pickens & Thompson, 1968). The allocation of responses should
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eventually exhibits exclusivity for the active device, regardless of its proximal position
(Pickens & Thompson, 1968; Corrigall & Coen, 1989).
Another property supporting the conjecture that behavior is indeed controlled by
response-dependent drug presentations is a dose-dependent change in self-administration
responding. Rates of responding or number of infusions obtained, (typically synonymous
measures), should follow as a direct function of the dose of drug available.  The function
obtained is generally an inverted U-shaped function (Katz, 1989).  Thus, low doses of the
drug maintain relatively low rates of responding.  As the dose increases, rates of
responding escalate as well, with responding peaking when a “moderate” dose is
available.  From this point, increases in dose result in decreases in the operant. As a
result, relatively lower and higher doses maintain similar rates of behavior and
approximately the same number of infusions are self-administered. However, some
drugs, namely nicotine and caffeine, have relatively flat dose-response curves within self-
administered doses.  With only a narrow range of doses that will maintain behavior, rates
of responding are generally low, do not fluctuate to a great degree and will diminish
outside the specific doses (Dworkin & Stairs, 2002).
Additionally, drug presentations non-contingent on behavior (pre-session or
within-session injections of a drug, within- or between-subject yoked infusions) should
not sustain the operant (Pickens & Thompson, 1968; Meisch, 1987). Of specific concern
when psychomotor stimulants are being assessed, this measure beings to demarcate drug
preference from the generalized increases in locomotor activity and direct effects of a
drug (Yokel, 1987).
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In concert with the aforementioned measures, the maintenance of behavior under
intermittent schedules of reinforcement also bolsters conclusions about  reinforcing
effects (Weeks and Collins, 1987). Although some events, still considered reinforcers, do
not maintain stable rates of behavior when schedule requirements exceed low ratios.
However, reinforcing efficacy may be generally inferred through maintenance of steady
rates of behavior when schedule parameters increase work requirements or reinforcers
become less frequent.
 Finally, administration of an agent that antagonizes the central action of the self-
administered compound can help clarify the mechanism of behavioral maintenance.
When a non-competitive, centrally acting receptor antagonist is administered, drug-
maintained responding will eventually cease if drug presentation was in fact the event
maintaining behavior (Yokel, 1987).
Variations in sensitivity to the behavioral effects of a drug are steeped in
environmental conditions and particular permutations of stimuli (Dews, 1955).
Behavioral history and previous drug exposure can affect the biological and behavioral
effects of a drug as well as changing the rates of acquisition and maintenance of drug
self-administration.  Moreover, conditions present at the time of drug administration
(stress levels, deprivation level, exteroceptive stimuli changes, schedules of
reinforcement, experimental paradigm) are also influential in behavioral reactivity to
drug effects. Environmental arrangements occurring after drug exposure (discriminative
stimulus effects, behavioral requirements) can also impact behavior at the time of
administration
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Subjected to parametric variation from numerous sources, a drug noted for its
behavior maintaining qualities, specifically nicotine, can dually serve as a presumably
aversive stimulus as well, as evidenced by behavior maintained by postponement of or
active avoidance of drug infusions of identical dose that also maintained behavior
(Goldberg & Spealman, 1983, 1982; Spealman, 1983). Thus, the capacity for a drug to
maintain and subsequently strengthen behavior appears not as a static effect, but rather a
dynamic feature dependent on the confluence of a host of behavioral and pharmacologic
elements.
Because behavioral maintenance via drug presentation is highly sensitive to
pharmacological and environmental specificities, some drugs, although consumed at
extremely high rates by human beings, initially do not seem to find parallel in an animal
model. Despite over one billion people worldwide abusing nicotine (Vainio, Weiderpass,
& Kleihues, 2001), the chemical in tobacco determined to maintain its consumption
(Stolerman & Jarvis, 1995), it failed to consistently serve as a reinforcer in the animal
self-administration paradigm (Griffiths, Brady, & Bradford, 1979; Dworkin, Vrana,
Broadbent, & Robinson, 1993) until the mechanisms potentiating its reinforcing
properties were fully elucidated. The initial published report of intravenous nicotine self-
administration was conducted using squirrel monkeys with their behavior maintained
under a second-order schedule (FI 1 min (FR 10:S)) (Goldberg et al, 1981).  The schedule
specified that each ratio completed under a FR 10 schedule result in a brief visual
stimulus (flash of a cue light  inside the chamber), with the first FR 10 requirement
completed after 1 minute producing both a brief stimulus presentation as well as a
infusion of nicotine (30 mg/kg). Behavior was maintained at high rates, the average being
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roughly one response per second. The operant was nearly eliminated when either saline
was substituted for nicotine or when a mecamylamine injection, a nicotinic antagonist,
was administered prior to the session. Responding diminished to nearly half the
aforementioned rate when the brief stimulus presentation was omitted (upon completion
of each FR 10). Seminal not only in terms of demonstrating an instance of behavioral
maintenance through nicotine presentation, but also because the results underscored the
importance of  conditioned stimuli, potentiating behavior of an otherwise operantly
ineffectual drug.
Succeeding studies, exploring the conditions that more readily expose the
reinforcing properties of nicotine, outlined specific parameters lending to its reinforcing
efficacy. Of specific concern has been the level of food deprivation necessary to maintain
self-administration.  Carroll et al. (1979, 1984) stressed the influence of food deprivation
as an imperative variable when examining drug maintained behavior, especially that of
central nervous system stimulants (Carroll, France, & Meisch, 1979; Carroll & Meisch,
1984).  Moreover, Dworkin et al. (1993) notably delineated the influence of concurrent
availability of non-drug stimuli, food and water, to effectually decrease responding
maintained by nicotine.
Another significant demonstration was the identification of specific experimental
variables that collectively increase nicotine-maintained responding (Corrigall & Coen,
1989; Donny, Caggiula, Knopf, & Brown, 1995). To achieve relatively high, stable rates
of behavior experimenters first established and maintained the operant through food
presentation rather than drug presentation.  The animals, male Sprague-Dawley rats, were
food deprived 18 to 24 hours prior to each session, with a supplemental diet consisting of
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20 grams of food per day (allowing for 133% body weight increase over 5 weeks). A
narrow range of doses were available during experimental sessions (.003, .030, .060
mg/kg/inf), the latter two maintaining behavior above that of vehicle (approximately 130
responses or 20 infusions per hour, under a FR 5). Temporal variables were imparted to
further furnish an environment occasioning nicotine self-administration: limited access to
the drug (sessions terminated after an hour) and a 60-second timeout situated
immediately after the reinforced response.  Finally, the role of  conditioned stimuli was
further established.  Experimental conditions provided a flash of a cue light coincident
with each target response and reinforcer delivery as well as a compound stimulus during
timeout periods (simultaneous tone presentation and ambient light alteration) (Corrigall
& Coen, 1989; Donny et al., 1995).  Comprehensively instantiated, the aforementioned
variables both mitigate prior issues of nicotine reinforcer efficacy and provide an
established model of nicotine self-administration upon which further manipulations may
be subjected.
With an archetypal mainframe to demonstrate reinforcing effects, it is the focus of
the current study to accordingly establish caffeine self-administration. However, as the
case with initial nicotine self-administration studies, attempts at behavioral maintenance
through caffeine infusions resulted in limited success.
Overview of Caffeine Self-Administration
Specifically, reports of the inability of IV presentations of caffeine to serve as
reinforcing event in rodents have been documented in the literature (Atkinson & Enslen,
1976; Briscoe et al, 1998; Collins et al, 1984). Atkinson & Enslen (1976) first explored
this topic with an experiment whereby animals were split into two groups: one group
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receiving injections of increasing doses of caffeine for up to 98 hours prior to the session
and the other group receiving no pre-treatment. When placed into an operant chamber in
which lever presses resulted in an IV infusion of caffeine, animals from the pre-treated
group self-administered caffeine for 3 to 4 days above the rate that was maintained by
saline infusions. However, the animals that received the saline pre-treatment never
acquired the operant (Atkinson & Enslen, 1976).
Moreover, Briscoe and colleagues (1998) initially maintained self-administration
behavior in male Sprague Dawley rats via 0.5 mg/kg/inf IV cocaine presentations.  These
sessions were followed by a series of trials which caffeine, ephedrine or their
combination was substituted for cocaine.  After stable self-administration behavior was
observed under .5 mg/kg/inf cocaine availability, each animal was randomly assigned to
receive one particular dose of caffeine (.25, .5, .75 and 1.0 mg/kg/inf), ephedrine (.25, .5,
.75 and 1.0 mg/kg/inf), or an infusion of their combination (.25 mg/kg/inf caffeine and
.125 mg/kg/inf ephedrine; .5 mg/kg/inf caffeine and .25 mg/kg/inf ephedrine; .7
mg/kg/inf caffeine and .5 mg/kg/inf ephedrine; or 1.0 mg/kg/inf caffeine with .7
mg/kg/inf ephedrine). Each dose as well as vehicle was tested for 3 days subsequent
cocaine self-administration, with eight animals being assigned to each dose. Neither
caffeine nor ephedrine was able to maintain behavior above levels engendered by saline
infusions. However, on the first day of substitution, 3 doses of the caffeine-ephedrine
solution (.25+.125; .5+25; .7+.5) maintained behavior significantly greater than those
observed under saline availability. Nonetheless, this effect was specific to the first day of
the compound’s availability, with behavior during successive sessions resembling
behavior maintained by saline infusions (Briscoe et al., 1998). Additional substitution
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testing with permutations of different doses of the caffeine and ephedrine compound
revealed the same general trend.  Three doses of the compound maintained high levels of
self-administration behavior (.7+.5 and .7+.7 mg/kg/inf ephedrine + caffeine; .7+.5
mg/kg/inf caffeine+ ephedrine), but, again, this tendency was confined to the first session
of substitution, declining almost immediately upon the following session (Briscoe et al.,
1998).
Echoing the same inconsistencies, Collins and colleagues (1984) implemented a
FR 1 self-administration schedule where 1.0 mg/kg/inf IV caffeine was available for
infusion. The operant was established through cocaine presentations and when caffeine
was substituted, highly variable behavior ensued.  The caffeine dose was then eventually
decreased to .1 mg/kg/inf in an attempt to re-establish and solidify responding. Although
two of the rats continued to respond, they did so in an erratic manner, whilst the
remaining four animals ceased responding completely (Collins et al., 1984).
Caffeine self-administration has been consistently reported as an ever-fluctuating,
highly variable behavior, regardless of the species studied. Several non-human primate
studies where caffeine was available under IV self-administration conditions have all
presented either extreme with-in subject, with-in condition variability (Deneau, Yanagita
& Seevers, 1969; Griffiths, Brady & Bradford, 1979), high degrees of between-subject
variability (Schuster, Woods & Seevers, 1969) inability for the drug presentation to
maintain the operant (Yanagita, 1970; Hoffmeister & Wuttke, 1973), or have necessitated
experimenter-induced injections to initiate responding (Deneau et al, 1969; Schuster et
al., 1969).
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Moreover, results obtained from studies examining oral self-administration of
caffeine have been equivocal at best.  In a bottle choice condition with drug-naïve rats,
preference for caffeinated water over non-caffeinated water was only evident when the
concentration of caffeine was very low, resulting in negligible cumulative caffeine intake
(Falk, Yosef, Schwartz & Lau, 1999). However, after an imposed 14-day “forced choice”
of highly concentrated caffeinated water (the only hydration available), the animals
consistently chose caffeinated water under “free-choice” conditions. Although still of
great import, this situation may imply a choice occasioned by caffeine dependence or
choice mitigated by negative reinforcement conditions rather than simple caffeine
preference. These results also necessitate the delineation of the degree to which the
discriminative stimulus effects of caffeine and the conditioned reinforcing effects of its
presentation influence self-administration of the compound.
Notwithstanding the inability to consistently showcase the presentation of
caffeine as a behavior-maintaining event, other paradigms have been implemented to
reveal other reinforcing effects of the drug. Although not without criticism for the
implications its results involve, conditioned place preference experiments have been used
to superficially asses a drug’s reinforcing efficacy through observation of choice behavior
via spatial location preference. The trials involve a choice between an environment which
has previously been paired with the discriminative stimulus effects of a particular drug
and an environment which has been paired with saline or a competing drug. Inferences
involving drug preference or the reinforcing properties of the elicited conditioned effects
of the drug are generally concluded through the relative amount of time spent in a drug-
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paired environment as compared to the alternative or via the percent of animals
exhibiting the place-preference (or alternatively an aversion).
Although few studies have been conducted using caffeine as a target drug, some
evidence has emerged to suggest that place preference may be sensitive to some of the
reinforcing mechanisms of caffeine. At a low doses (.32, 1.0, 1.5, 3.2, 5.6 and 10 mg/kg,
i.p.), caffeine was found to serve to occasion place preference (Patkina & Zvartau, 1998;
Bedingfield, King & Holloway, 1998). However, at higher doses tested (12, 25 and 50
mg/kg, i.p.) it was found to potentiate place-aversion behavior (Patkina & Zvartau, 1998).
To further elucidate caffeine’s reinforcing effects in relation to other drugs, it has been
used as a challenge drug, pinned against both ethanol and cocaine. When animals,
previously exposed to both drugs, were given a choice between a cocaine-paired
environment (5 mg/kg, i.p.) and a caffeine-paired environment (1.5 mg/kg, i.p.), all of the
eight animals tested chose the cocaine-paired environment on every trial (Patkina &
Zvartau, 1998). However, when animals were given a choice between an ethanol-paired
compartment (1.2 g/kg, i.g.) and a caffeine-paired environment (1.5 mg/kg, i.p.), equal
time was spent in each environment, across all trials, implying no preference between the
treatments.  Therefore, the conditioned place preference paradigm reveals some of the
dose-related reinforcing properties of caffeine and provides a relational comparison in the
context of other drugs.
Effects of Caffeine on Schedule-Controlled Behavior
Although limited research has been conducted concerning the effects of caffeine
on schedule-controlled behavior, it is nonetheless a key aspect in a discussion of the
behavioral effects of caffeine.
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Caffeine administration has been shown to have significant effects on schedule-
controlled behavior.  When acutely administered, caffeine has dose-dependent effects on
rates of behavior.  Specifically, when behavior of squirrel monkeys is maintained on a FI
180 s schedule of food presentation, a moderately low dose (1.5 mg/kg, im) significantly
increased rates of responding in all animals at an average of 140% of that observed under
control conditions.  However, after a relatively high dose (28.0 mg/kg, im), behavior was
significantly decreased, with rates of behavior declining to 20% of the rate emitted under
control conditions (Katz and Goldberg, 1987).  Moreover, chronic caffeine administration
did not seem to reliably affect behavior when administered after the experimental session,
but when chronically administered with injections occurring prior to sessions, the same
doses which increased and decreased behavior under acute administration had similar
effects on behavior (Katz and Goldberg, 1987). In fixed ratio schedules of food
maintained behavior, low doses of caffeine have little effect, while high doses (30 and 56
mg/kg) greatly reduced rates of responding (Glowa and Spealman, 1984).  These results
have been supported by similar findings, whereby acute administration of 10.0 mg/kg, im
caffeine have increased rates and 30.0 mg/kg decreased rates of behavior under a FI 300 s
shock avoidance schedule (Howell, 1993).
Decreases in food maintained behavior are also evident when caffeine is
chronically administered to rats.   When administered caffeinated drinking water (3
mg/ml) rates of behavior maintained under a FI 5 minute schedule of food presentation
were temporarily decreased.  Peak effects were characterized by a 60% decrease in
response rates and 30% decrease quarter-life values and occurred 72 hours after
caffeinated water availability.  However, these effects soon diminished and complete
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tolerance developed after peaked 5 days of caffeine exposure (Gasior, Shoaib, Yasar &
Goldberg, 1998).
Caffeine also seems to alter schedule induced responding.  When Sprague Dawley
rats were exposed to a FI 90 s schedule of food presentation and given free access to a
water spout located above the lever, caffeine differentially and dose-dependently affected
the observed behaviors.  When baseline rates of lever pressing were high, caffeine did not
increase rates of behavior at any dose tested (10, 30, 56, 100 mg/kg), but decreased rates
at higher doses (56 mg/kg, 100 mg/kg).  When lever pressing baseline rates were lower,
none of the doses tested altered rates of lever pressing.  Regardless of an animal’s
baseline rates, the high dose of caffeine (100 mg/kg) suppressed licking behavior in all
animals, however low doses (10, 30 and 56 mg/kg) were able to decrease licking in some
animals (McMillan, 1979).
Demonstration of the Reinforcing Effects of Caffeine in Humans
Despite the presence of equivocal evidence emerging out of animal laboratories,
research concerning the behavioral effects of caffeine seems to be less ambiguous.  The
reinforcing effects have reported in a variety of experimental settings  (Griffiths &
Mumford, 1995).
Aligning with basic behavioral pharmacology principles, caffeine adheres to an
inverted U-shaped function in human self-administration settings. Thus, low doses of
caffeine (25 mg per cup of coffee) maintain consumption  at low levels, but at greater
rates those engendered by control (decaffeinated coffee) (Oliveto, Hughes, Pepper,
Bickel & Higgins, 1991). This behavioral maintenance was consistent among subjects,
regardless of the amount of caffeine they normally ingest.  Moreover, when 50 or 100
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mg/per cup coffee was available, rates of consumption increased, with more caffeine
being ingested by a greater percentage of the subjects (Oliveto et al., 1991).   In
concordance, when doses above 100mg/unit were available for self-administration, rates
of behavior decreased as a function of increasing dose (100 to approximately 350 mg),
with very high doses per unit (400 mg and higher) prompting avoidance behavior
(Griffiths & Woodson, 1988).
Choice and consumption behavior are sensitive discriminative stimulus effects of
the dose consumed as well.  Evans & Griffiths (1992) conducted an experiment using a
series of choice trials.  Free choice trials noted preference between a caffeinated and non-
caffeinated beverages, while forced-choice trials were present to ensure subjects
experienced both options.  Their data reflected the same aforementioned trend of a dose-
dependent behavior.  However, after examining the data, it was subsequently discovered
that there was a strong relationship between those subjects who chose the caffeinated
beverage and their reports of positive subjective effects after consuming the caffeinated
beverage.  Moreover, these same subjects were more likely to have reported negative
subjective effects after forced-choice trials where the non-caffeinated beverage was
presented. Likewise, the subjects who consistently chose the non-caffeinated beverage
where those subjects who reported aversive subjective effects upon forced consumption
of the caffeinated beverage (Evan & Griffiths, 1992).     
Although somewhat dismissed by the animal literature, there has been equivocal
evidence that the behavioral requirements following choice trials may influence self-
administration of caffeine (Silverman, Mumford & Griffiths, 1994).  As is the case with
other drugs (cocaine, d-amphetamine and methylphenidate), caffeine self-administration
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is sensitive to the conditions that follow drug availability (Stoops, Lile, Fillmore, Glaser
& Rush, 2005).  Therefore, the implication is that self-administration behavior of certain
stimulants may increase when a task requiring attention or vigilance is necessary.
Another factor influencing caffeine self-administration is dependence.  Although
the mechanism is unclear, withdrawal symptoms may have discriminative stimuli effects
which potentiate caffeine consumption.  Moreover, subsequent to ingestion, subjects
report caffeine administration as assuaging the aversive subjective effects of withdrawal
while concomitantly increasing the subjective effects of the dose consumed (Griffiths,
Bigelow & Liebson, 1989; Hughes, Hunt, Higgins, Bickel, Fenwick & Pepper, 1992;
Hughes, Oliveto, Bickel, Higgins & Badger, 1993).  
Emerging evidence suggests that the presence of withdrawal symptoms do not
exclusively set the occasion for caffeine consumption.  When partial deprivation is
experimentally induced, the effects are incongruous with the aforementioned findings.
While complete deprivation was associated with the subjective effects of withdrawal,
partial deprivation did not occasion significant withdrawal symptoms.  Regardless,
neither partial nor complete deprivation prompted a substantial increase in self-
administration, lending to the conclusion that deprivation nor aversive subjective effects
solely potentiate caffeine consumption (Mitchell, de Wit & Zancy, 1994). Therefore, as
evidenced by the literature from the human laboratory, caffeine availability serves as a
reinforcing event under specific circumstances.
Pharmacology of Caffeine
At behaviorally active doses, caffeine, a neuromodulator, has multiple effects on
the central nervous system. The primary action of caffeine is one of adenosine receptor
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blockade, competitively inhibiting the binding of adenosine receptor ligands (Snyder,
Katims, Annau, Bruns & Daly, 1981). Hence, the behavioral effects of adenosine analogs
are effectively antagonized by caffeine in a manner that implies competitive interaction at
the receptor level, inferred through a rightward shift in the adenosine dose-response curve
(Barraco, Coffin, Altman, & Phillis, 1983; Coffin & Spealman, 1987).
Of the four adenosine receptors identified in human brains, A1, A2A, A2B, and A3,
caffeine exhibits the greatest amount of affinity for A2A, A1 and A2B receptors, with the
antagonism potency being most complete at the A2A receptor (Fredholm, Battig, Holmen,
Nehlig, & Zvartau, 1999; Daly & Fredholm, 1998). The primary behavioral correlate of
adenosine antagonism is a dose-dependent heightening of locomotor activity, an
enhancement of which is four-fold of that under vehicle-treatment conditions, albeit
exhibited with less consistency than that of amphetamines (Snyder et al., 1981).
Moreover, as previously mentioned, administration of methylxanthines produces an
increase of schedule-controlled behavior in both rodents and monkeys (McKim, 1980;
Glowa & Spealman, 1984; Spealman & Coffin, 1988). Further behavioral support of the
aforementioned action is evident in A2A knock-out mice, (animals which do not have the
receptor), upon which a caffeine injection produces only behavior suppressing effects,
similar to that of an agonist (Ledent, Vaugeois, Schiffmann, Pedrazzini, El Yacoubi,
Vanderhaeghen, 1997).
Additional effects, non-centrally generated, are hypothesized as resultant effects
of antagonism of endogenous adenosine and include lipolysis (the breakdown of fat
stored in adipose tissue cells), increased heart rate, increased release of catecholamines,
and increased renal blood flow (Fredholm, 1985).
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  Previously suggested to be a function of benzodiazepine receptor blockade, the
effects of methylxanthines, particularly caffeine, are significantly more potent at
adenosine receptors than benzodiazepine receptors (reported as much as 100 times so)
and a correlation between the activation of the two mediated by methylxanthines has
been disregarded (Snyder et al, 1981). 
Of great behavioral and biological import is caffeine’s secondary action of
dompaminergic activity enhancement. Mediated through adenosine antagonism, this
interaction appears to be a function of the colocalization of the two receptors (Ferre et al,
1992; Garrett & Griffiths, 1996), with dense populations of A2A receptors found in the
caudate/putamen, nucleus accumbens, and tuberculum olfactorium (Daly & Fredholm,
1998). Thus, A2A receptors are strictly positioned in dopamine-innervated areas and
follow the same postsynaptic arrangement as postsynaptic D2 and D1 type receptors
(Ferre et al., 1991, 1992).  This colocalization has been purported to induce two types of
interactions between the two receptor sub-types: a decrease of D2 agonist affinity via
activation of A2A receptors and a decrease of cyclic AMP (induced through A2A receptor
stimulation) through the activation of D2 receptors (Ferre et al., 1992). Thus, an agent
with properties of A2A receptor antagonism, such as caffeine, may both intensify the
potency of endogenous dopamine, an effect specific to D2 receptors, and diminish the
agonizing effects of cyclic AMP on GABAergic neurons (Daly & Fredholm, 1998).
Translating this biochemical interaction into behavioral terms has resulted in
research which garners support for a dompaminergic mediation of the ensuing behavior
upon caffeine administration. Akin to other drugs which principally act as dopamine
agonists, caffeine increases locomotor activity, with these effects attenuated by selective
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D1 and D2 receptor antagonists (Garrett & Holtzman, 1994a). Accordingly, animals which
display locomotor activity tolerance to caffeine exhibit cross-tolerance behavior to both
D1 and D2 receptor agonists (Garrett & Holtzman, 1994b). Moreover, when dopamine
synthesis is inhibited, caffeine-induced locomotor activity enhancement is likewise
diminished (Finn, Iuvone & Holtzman, 1990; Garrett & Griffiths, 1996).
In consideration of the aforementioned research implications, it is the focus of the
current study to effectively establish a caffeine dose-response curve, utilizing a rodent
self-administration model to attempt to further qualify IV caffeine presentations as a
behavior maintaining event, stressing the importance of both behavioral and
pharmacological variables.
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METHOD
Subjects
Serving as subjects were 32 experimentally naïve, drug naïve, male Sprague-
Dawley rats (Harlan Intl., Indiana, IN). The animals were approximately 3 months old at
the beginning of the experiment and were kept at 75% of their free-feeding weight
(approx. 250-350 g), with supplemental feedings consisting of 15-20 grams. Individually
housed, the animals were kept in conditions which provided constant free access to water
and saline catheter flushes every hour. Animals were housed in a temperature and
humidity controlled environment with lights operating on a 12:12 reverse light/dark cycle
(lights on 1900 to 0700 hours). The experimental facility was accordance with the
guidelines of the Institutional Animal Care and Use Committee and the Guide for Care
and Use of Laboratory Animals of the Institute of Laboratory Animal Resources.
Surgery
Under sodium pentobarbital (50 mg/kg, i.p.) and atropine methyl nitrate (10
mg/kg, i.p.) anesthesia (SIGMA Chemical Co., St. Louis, MO), a chronic in-dwelling
intravenous catheter was implanted into the rats’ right jugular vein. Passed
subcutaneously and secured to the vein with silk sutures, the catheter exited through the
animals back via a protective back-plate covering (composed of Nalgene® plastic,
Teflon, plastic screws and stainless steel covering). The external portion of the catheter
was protected by a stainless steel leash, attached to both the back-plate and to a liquid
swivel. Post-operatively, tetracycline and heparinized saline (.05ml) were administered
(i.v.). Catheter patency was ensured by an i.v. infusion of sodium methohexital (Brevital,
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0.05 ml/injection), conducted at least once every 3 days, 2 hours prior to the experimental
session.
Drug
Caffeine anhydrous (C9H10N4O2; 1,3,7-trimethylxanthine), obtained from SIGMA
Chemical Co. (St. Louis, MO) was dissolved in physiological saline and made available
in doses of .400 mg/kg/inf; .625 mg/kg/inf; and .750 mg/kg/inf.
Apparatus
Experiments were conducted operant chambers encased in sound attenuating
receptacles (MED Associates, St. Albans, VT). The exterior of each chamber, specifically
modified to accommodate drug-self administration, was equipped with a high-speed
microliter drug syringe pump (MED Associates, model PHM-103), a counterbalanced
arm (designed to provide the appropriate pressure on the catheter’s encasing material), a
food pellet dispenser (Gerbrands, model G5100), a tone generator, a 28 V houselight, and
a ventilation system. Each chamber, constructed of stainless steel side walls and Plexiglas
anterior and posterior walls and ceiling lid, displayed exterior dimensions of 23 cm x 21.5
cm x 21.25 cm (MED Associates). The interior of the chamber (21.75 cm x 20.25 cm x
20 cm) consisted of a gridded floor area (comprised of 15 cylindrical metal bars, spaced
1.25 cm apart) and was equipped with two levers, each located 3 cm above gridded floor.
One lever (designated the active lever, initiating either the drug pump or the feeder) was
located on the right wall, with a green cue light located 5 cm directly above the lever and
the food aperture located 5 cm to the left of the lever. The inactive lever (responses upon
which were recorded but had no scheduled consequence) was located on the left wall, 4
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cm from the chamber’s posterior wall, and had a red cue light located 5 cm above the
lever.
Procedure
Prior to surgery, lever pressing behavior was shaped and maintained by food
pellet presentation (45mg), (active lever responses only). The initial schedule, a FR 1,
gradually increased until the terminal schedule of reinforcement, FR 10, was reached and
subsequently maintained. Ambient chamber conditions were: an extinguished houselight,
an illuminated green cue light above the active, an illuminated red light above inactive
lever, with white noise present. Each lever press response was accompanied by both a
brief (.5 seconds) cue light extinguishment and a feedback click. After each food pellet
delivery, a 60 second time-out ensued, characterized by a tone presentation and
illumination of the chamber via the 28v houselight, with both stimuli presented for the
full 60 seconds of the time-out period. Responses during timeout periods had no
scheduled consequence, but were recorded. The same held true for inactive lever
responses during the session and in time-out periods. Sessions were 60 minutes in
duration with no limit on the number of reinforcers obtained.
Subsequent to surgery, caffeine was available under a FR 1 schedule of i.v. drug
presentation (50 ml of caffeine, 100 ml/sec). Responding produced the same permutation
of stimuli as the food maintained behavior, with the only difference being the initiation of
the drug pump instead of the firing of the feeder. Doses of caffeine were: .400 mg/kg/inf;
.625 mg/kg/inf; and .750 mg/kg/inf (with heparinized saline used as vehicle for probe
trials).
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The self-administration behavior of two groups of animals was examined. One
group of animals (n=4) were first given access to .400 mg/kg/inf initially, then when the
behavior of each animal stabilized, the dose was switched to .750 mg/kg/inf availability.
The other group of animals (n=4) began with .750 mg/kg/inf availability and were
subsequently given access to .625 mg/kg/inf. Probe trials, in which saline was substituted
for caffeine for the entire duration of the session, were implemented when an animal
displayed consistent self-administration of the dose currently available for administration.
Novel dose availability or saline probe sessions were instantiated when a particular
animals’ behavior had stabilized and the current dose was reliably self-administered.
Criteria for stability were based upon review of each animals’ data for: a least five days
of relatively consistent self-administration behavior, behavior which did not approach
levels resembling behavior under saline availability, or responses on the active lever
proportionally greater than those on the inactive lever once reliable self-administration
was observed. Moreover, it was also considered essential to observe an appreciable
decrease in behavior upon saline substitution before reintroducing a dose of caffeine,
with probe trials being presented to each animal at least once during the series of sessions
in which a particular dose of caffeine was available.
After each drug self-administration session, while animals were still experimental
chamber, catheters were flushed with .1 ml of heparinized saline to clear the drug
completely from the line. Animals were then immediately placed into home cages and
their catheters connected to saline pumps. One hour afterward (post-session), all animals
were fed 15 to 20 grams of Lab Diet rat food, depending on their weight.
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RESULTS
Effect of Dose & Schedule on Number of Infusions
Each group’s (n=4) data was analyzed using a separate Two-Way ANOVA,
analyzing the main effects of dose and schedule on the number of infusions obtained.
The first group was exposed to the following conditions: 0.4 mg/kg/inf under a FR 1,
0.75 mg/kg under a FR 1 and FR 2, and saline under FR 1.  There was a significant effect
of dose on the number of infusions self-administered under a FR 1 schedule (F (3, 62)=
14.712, p < .05).  There was also an effect of schedule under the  0.75 mg/kg/inf
condition (F (1, 32) = 7.956, p <.05).   Holm-Sidak Pairwise Multiple Comparison
revealed that each dose under a FR 1 schedule maintained responding at a level
significantly different from that of vehicle under a FR 1 schedule (.04mg/kg/inf dose:
(t=2.225, p=.027); 0.75 mg/kg/inf: (t=4.219, p=.02)).   
The second group’s (n=4) data was also analyzed using a Two-Way ANOVA,
examining the effects of dose and schedule on number of infusions.  This group was
exposed to the following conditions: 0.625 mg/kg/inf under both FR 1 and FR 2, 0.75
mg/kg/inf under FR 1 and FR 2, and saline under FR 2.  There was a main effect of dose
(F (2, 59) = 13.21, p < .05 ), a main effect of schedule (F (1, 48),  p < . 05), and an
interaction between schedule and dose (F (2, 76) = 10.92, p < .05).  A Holm-Sidak
Pairwise Multiple Comparison delineated the effects.  The .625 mg/kg/inf dose
maintained behavior to a significantly greater degree than the .75 mg/kg/inf dose
(t=5.119, p < .01) under a FR 1 schedule.  There were no differences detected between
the two doses under an FR 2 schedule and neither dose was significantly different from
vehicle FR 2 conditions (0.625 mg/kg/inf: t = 1.231, p > .05; 0.75 mg/kg/inf: 1.002, p <
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.05).  There was a significant interaction between dose and schedule (F (1, 45) = 8.071, p
< .05) so that behavior observed under the .625 mg/kg/inf FR 1 was significantly
different from all other schedule permutations (t = 4.44, p < .05).
Effect of Dose & Schedule on Pause Duration
Again, each group’s (n=4) data was analyzed using a separate Two-Way
ANOVA, examining the effect of schedule and dose on pause duration.  The first group
was exposed to the following conditions: 0.4 mg/kg/inf under a FR 1, 0.75 mg/kg under a
FR 1 and FR 2, and saline under FR 1.  There was a significant effect of dose on the
pause duration under a FR 1 schedule (F (3, 62)= 12.933, p < .05).  There was also an
effect of schedule on pause duration under the 0.75 mg/kg/inf condition (F (1, 32) =
7.956, p <.05), with the FR 2 condition occasioning longer pauses than those observed
under the FR 1 condition.   Holm-Sidak Pairwise Multiple Comparison indicated that
each dose under a FR 1 schedule induced pausing that was significantly shorter in
duration than pausing observed under vehicle FR 1 conditions (.04mg/kg/inf dose:
(t=2.225, p=.027); 0.75 mg/kg/inf: (t=4.219, p=.02)).   
Pausing behavior was analyzed via a Two-Way ANOVA for the data of second
group (n=4) as well.  There was a main effect of dose (F (2, 59) = 12.82, p < .05), a main
effect of schedule (F (1, 48) = 10.952, p < .05), and an interaction between schedule and
dose (F (2, 76) = 11.014, p < .05) on pause duration,  A Holm-Sidak Pairwise Multiple
Comparison was used to identify the specific results.  The .625 mg/kg/inf dose
occasioned a significantly shorter pause than the .75 mg/kg/inf dose (t=4.53, p<.05)
under a FR 1 schedule.  Moreover, both doses engendered pauses that were significantly
different than those observed under vehicle conditions (.625 mg/kg/inf: t = 6.781, p < .01;
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.75 mg/kg/inf: 4.441, p < .05).  There were no differences in pause duration detected
between the two doses under an FR 2 schedule, but behavior under both doses was
significantly different from behavior under vehicle FR 2 conditions (0.625 mg/kg/inf: t =
3.946, p < .05; 0.75 mg/kg/inf: t = 2.75, p < .05).  There was a significant interaction
between dose and schedule so that mean pause duration observed under the FR 1
schedule implementing the .625 mg/kg/inf was significantly different from all other
schedule permutations (F (1, 45) = 7.923, p < .05).
Effect of Dose & Schedule on Cumulative Consumption
Figure 5 presents cumulative caffeine intake as a function of both the dose
available for self-administration and the ratio requirements instantiated.  Expressing the
average amount of caffeine consumed per session in milligrams, this graph simply
converts the infusion data in Figure 1 to convey average intake levels. Each group’s
(n=4) data was analyzed using a separate Two-Way ANOVA.  When analyzing the data
from the first group, there was no significant effect of dose detected on the amount of
caffeine self-administered under a FR 1 schedule (F (1, 46)= 4.322, p > .05).  However,
there was an effect of schedule under the  0.75 mg/kg/inf condition (F (1, 32) = 7.956, p
<.05), with the FR 1 schedule occasioning more caffeine consumption than the FR 2
schedule.
When analyzing the second group’s data, there was a main effect of dose (F (1,
35) = 11.452, p < .05 ), a main effect of schedule (F (1, 48) = 10.74,  p < . 05), and an
interaction between schedule and dose (F (2, 76) = 10.677, p < .05) on amount of
caffeine consumed.  A Holm-Sidak Pairwise Multiple Comparison delineated the effects.
The .625 mg/kg/inf dose engendered total consumption to a significantly greater degree
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than the .75 mg/kg/inf dose (t=5.119, p < .01) under a FR 1 schedule.  There were no
differences detected between the two doses under an FR 2 schedule (0.625 mg/kg/inf: t =
1.031, p > .05; 0.75 mg/kg/inf: 2.313, p >.05).  There was a significant interaction
between dose and schedule (F (1, 45) = 8.071, p < .05) so that total consumption
observed under the .625 mg/kg/inf FR 1 was significantly different from all other
schedule permutations (t = 5.23, p < .05).
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DISCUSSION
As evidenced in Figure 1, behavior seems to be sensitive to both the caffeine dose
available for self-administration as well as the schedule requirements for its infusion.
Duly, the dose which occasioned the highest levels of responding (.625 mg/kg/inf) was
only the most effective in maintaining the behavior when a FR 1 schedule was in effect.
When the schedule parameters were raised to a FR 1 schedule, regardless of dose
available, behavior substantially decreased, lending to the conclusion that increases in
ratio values have a considerable effect on behavior maintained by caffeine presentations.  
Although not following the strictest of interpretations, the data (Figure 1) may
loosely adhere to the typical inverted U-shape function, observed with most drugs self-
administered by animals. While still a relatively flat function, inferences may still be
viable, specifically that there seems to be a narrow range of doses able to maintain
behavior. Additionally, observed levels of self-administration, although deemed distinct
from those engendered by saline availability, where neither elevated nor excessive,
relative to other drugs. Albeit, support for these conclusions may be garnered from
nicotine self-administration studies which purport the same trends (Corrigall & Coen,
1989; Donny, Caggiula, Knopf, & Brown, 1995). However, when individual subject,
with-in trial data were examined, at the highest levels observed, although quite
intermittent and infrequent, self-administration behavior approximated the maximum
allowable by session parameters.    
Moreover, analyzing behavior occurring during probe trials, it appears that
substituting saline for caffeine was very effective in decreasing behavior to minimal
levels. However, more research is warranted to hypothesize more accurately about the
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mechanism of behavioral maintenance.  It remains unclear if the indirect effects of
caffeine presentation were maintaining behavior. The degree to which the direct effects
of the drug (generalized increases in locomotor activity) controlled self-administration
need to be further analyzed. Nonetheless, in the confines of the present experiment, the
allocation of behavior between the active and inactive lever was examined and revealed
that after repeated exposure to the experimental arrangement the clear majority of
behavior was distributed toward the active lever. Not without limitations and interpreted
as preliminary, this effect has been an established observation in self-administration
studies concerning drugs of abuse (Meisch, 1987).
In a more detailed analysis, the data that appear in Figure 4 display pause duration
as a function of both caffeine dose and schedule parameters. Pause length is a measure,
typically collected when employing fixed schedules, which quantifies the time between
the onset of the last infusion and the initiation of responding (and, in the present
experiment, the consistent inclusion of the 60 second time-out period). Informative in its
implications, pause length has been observed to be positively correlated with increases in
reinforcer quantity (Lowe, Davey and Harzem, 1974; Harzem and Harzem, 1981), with
the same relationship evident when ratio requirements are increased (Ferster & Skinner,
1957).  As displayed in Figure 4, the latter statement seems to be in effect for each dose
tested. However, the incongruence with the former notion is a question framed in
response-reinforcer relations. If the notion of increased pause duration as occasioned by
increased reinforcer magnitude is thought of in the same manner of increases in
behavioral maintenance then there seems to be less of a discrepancy, further established
by the greatest pausing occurring during saline sessions. Moreover, the U-shaped trend of
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pause duration, usually referred to as an inter-injection interval, as a function of dose
availability has been well documented in the behavioral pharmacology literature (Katz,
1989).
The last figure introduced, Figure 5, displays mean caffeine consumption per
session, across animals. Presented for the perspective which it demands, the data
presented is only striking when relationally framed. When behavior was most potent
(emitted under a FR 1 schedule where .625 mg/kg/inf was available), the average amount
of caffeine consumed approximated 5 mg. With the average animal’s weight being 300
grams, this resulted in 16.67 mg/kg in one session. Relationally, if the same dose were to
be administered to an average 70 kg human being, it would equate to 1166.67 mg, or 1.17
grams of caffeine. With the average mug of coffee containing approximately 60 mg of
caffeine, this tabulates metaphorically as consuming almost 20 mugs of coffee in an
hour’s time. The least amount of cumulative consumption observed, about 1 mg, would
equate to almost 4 cups of coffee, if the analogy may be extended, considering the
disparate routes of administration.
Although a modest experiment, the data presented may carry implications which
are of interest and import. Not generally typified as a drug of abuse, caffeine has a profile
of a more whimsical dependence: a necessary collegiate companion, a cigarette’s
complement, a morning essential. However, there is a contingent expressing a heightened
level of concern about its ubiquitous consumption. Compelling in its contentions, the
hypothesis builds the evidence for the assertion that caffeine consumption may be a
model of drug abuse (Holtzman, 1990; Griffiths & Mumford, 1995). Removed from the
political classification of drugs and the laws which follow, the distinction between a drug
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which carries abuse liability and those which are deemed harmless is subject to the
interpretation of the available data.                                                                          
Evidence supporting a model of drug abuse stem from the observation of
withdrawal symptoms, tolerance, discriminative stimulus effects and reinforcing effects
associated with caffeine consumption in animal laboratories.  Although there is not a
great deal of research concerning withdrawal symptoms in animals, the behavioral effects
occurring after chronic caffeine consumption cessation include disruption of both
schedule controlled behavior (Carroll, Hagen, Asencio & Brauer, 1989) and locomotor
activity (Finn & Holtzman, 1986).   A dose-dependent effect, these interruptions appear
when doses exceeding 70 mg/kg/day (in water) are consumed.  Moreover, these effects
may be observed 24 hours after the last dose of caffeine was ingested and may last for a
few days (Finn & Holtzman, 1986).                                                                  
Tolerance to the behavioral effects of caffeine have also been consistently
demonstrated in animals.  Rats became completely tolerant to increases in locomotor
activity after repeated consumption of 40 mg/kg/day via water.  Tolerance has been
observed to be so marked that doses 10 to 30 times greater than those producing a
significant effect in drug-naïve animals did not overcome the locomotor tolerance
exhibited by the rats that chronically consumed caffeine (Finn & Holtzman, 1986).
Moreover, rats receiving daily 32 mg/kg, i.p. injections before operant experimental
sessions displayed complete tolerance after a week of caffeine exposure.  The dose
response curves revealed a six-fold shift to the right. There was a disruption in behavior
when caffeine was initially administered, however the effects were temporary, lasting
only a few days (the initial few days of the experiment) (Carney, 1982).  Thus caffeine
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tolerance is exhibited rather rapidly and with continuous use seems to be insurmountable
(Holtzman, 1983; Finn & Holtzman, 1986; Nehlig, 1999).  Cross-tolerance to locomotor
activity effects appears exclusive, only exhibited upon administration of other
methylxanthines and not displayed toward the discriminative stimulus effects of
amphetamine, methylphenidate or cocaine (Finn & Holtzman, 1987, 1988; Holtzman,
1990).
The discriminative stimulus effects induced by caffeine injections are readily
distinguished from those of saline, evidenced by rats responding to drug-appropriate
stimuli in drug-discrimination trials.  However, when lower doses of caffeine were
administered (10 mg/kg, i.p.) the effects were more likely to be associated with the
discriminative stimulus effects of amphetamine than were higher doses of caffeine (30
mg/kg, i.p.) (Holtzman, 1986).
Although previously not very well established, the reinforcing effects of caffeine
have been observed in animals. Conditioned place preference studies have demonstrated
that lower doses of caffeine (.32, 1.0, 1.5, 3.2, 5.6 and 10 mg/kg, i.p.), can prompt a
preference for environments associated with caffeine presentation over an environment
paired with saline (Patkina & Zvartau, 1998; Bedingfield, King & Holloway, 1998).
When response-dependent iv infusions are available, regardless of species tested,
inconsistencies have emerged, involving within-subject, within-condition variability
(Deneau, Yanagita & Seevers, 1969; Griffiths, Brady & Bradford, 1979) and between-
subject fluctuations (Schuster, Woods & Seevers, 1969).  However, the incorporation of
the results of the present study provide evidence that iv caffeine infusions can maintain
behavior under specific circumstances and reinforce behavior necessary in accessing the
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drug. When the evidence is examined in its entirety, caffeine consumption in animals
very well may align with the assertion that the behavior surrounding the ingestion of
caffeine is comparable to that, if not serving as a model of, drug abuse.
Examining the DSM-IV for the criteria outlining substance dependence, there are
four listings which align with the current human caffeine research (Griffiths & Mumford,
1995). In an attempt to delineate how caffeine consumers fit these criteria, Hughes and
colleagues (1998) conducted an interview-style study whereby caffeine consumers were
asked to identify which symptoms they felt they exhibited. Although requiring a tentative
interpretation due to the self-report nature of the data collection, the authors reported that
the majority (56%) of the 162 participants confirmed that in spite of repeated attempts
and a strong conviction to cease, control or minimize use, their caffeine consumption had
continued, an indication of substance abuse as listed in the DSM-IV. Furthermore, half of
the respondents reported “spending a lot of time with” caffeine, approximately a third of
participants reported that they regularly consume more intended, and 20% met the
requirements for clinical withdrawal symptoms (Hughes et al, 1998). Thus, with
confirmatory symptoms aggregated, the estimate of participants interviewed who exhibit
the symptoms which meet the criteria for caffeine dependence approached 30% (Hughes
et al., 1998). Therefore, while usually relegated as a harmless ingredient or food additive,
there remains evidence which counters this notion, propelling concern of dependence
potential.
Beyond hypotheses of dependence, there is further reason to explore caffeine’s
effects, as there are data which suggest that the drug may potentiate the discriminative
stimulus effects of other drugs, agents which carry high abuse liability. Specifically, a
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well documented effect has been when cocaine self-administration (0.5 mg/kg/inf) is
established in rats and is subsequently extinguished, caffeine injections prior to the
session or within the experimental setting (5.0, 10.0 and 20.0 mg/kg, i.p.) have
occasioned re-instatement of cocaine seeking (a resurgence of the previously
extinguished behavior) (Worley, Valadez & Schenk, 1994; Schenk, Worley, McNamara
& Valadez, 1996; Schenk & Partridge, 1999; Green & Schenk, 2002). To further
delineate the biochemical correlates of this effect, the adenosine A2 antagonist, DMPX,
has been administered upon extinction and has not reinstated self-administration behavior
(Green & Schenk, 2002). Moreover, when a non-selective A1/A2 agonist (NECA) is
administered prior to caffeine, it does block caffeine’s reinstatement effects, however it
also induced hypothermic and extreme sedative effects, so conclusions may be
considered provisional (Green & Schenk, 2002). However, the A1/A2A antagonist
CGS15943 both maintains self-administration and reinstates cocaine seeking in baboons,
while leaving food-seeking behavior unaffected (Weerts & Griffiths, 2003).
 To reveal the dopaminergic underpinnings of caffeine-induced cocaine seeking,
the D1-like antagonist, SCH 23390, and the D2-like antagonist, eticlopride, administered
separately prior to caffeine in extinction trials, markedly attenuated caffeine-induced
reinstatement (Green & Schenk, 2002). Additional support for a dopaminergic
mechanism has been the report of cocaine reinstatement via pretreatment of a D2-like
agonist (7-OH-DPAT), and a D2/D3 agonist (quinpirole), while a D1 agonist did not
mimic the aforementioned effect (Garret & Holtzman, 1994a). Thus, the current
hypothesis is one which disregards the influence of an A2 antagonism mechanism,
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attributing caffeine’s ability to reinstate cocaine seeking to a dopaminergic-mediated
mechanism.
Similarly, caffeine alters the behavioral effects of nicotine as well. Rats
chronically exposed to high doses of caffeine (3 mg/ml) in their drinking water acquire
nicotine self-administration (.03 mg/kg/inf) at a rate well above that of control animals
not exposed to caffeine (Shoaib, Swanner, Yasar & Goldberg, 1999). Likewise, when
maintained at low doses of caffeine (.25 mg/ml), rats acquire nicotine discrimination (.4
mg/kg, i.p.) at an accelerated rate, compared to animals maintained at higher doses of
caffeine (1.0 mg/ml) as well as control animals (Jaszyna, Peters & Goldberg, 2000). In
addition, this effect translates to humans maintained on higher doses of caffeine (200
mg/70 kg, p.o., t.i.d.). Increasing the stimulant-like discriminative stimulus effects of
both low (1.0 mg/kg, i.v.) and high (2.0 mg/kg, i.v.) doses of nicotine, the oral caffeine
maintenance also depleted the negative effects reported upon administration of the low
dose of nicotine under placebo maintenance (Jones & Griffiths, 2003). Moreover,
nicotine administration has been shown to have little to no effect on anxiety levels when
consumed alone (via nicotinized smoke); however caffeine-induced anxiety (generated
by coffee drinking) may diminish upon nicotine consumption (Rose & Behm, 1991).
Moreover, the researchers found that chronic caffeine also produced sensitization
the effects of both amphetamine and cocaine, with both drugs (amphetamine: .56, 1.0 and
1.7 mg/kg, i.p.; cocaine: 5.6, 10.0 and 17 mg/kg, i.p.) potentiating increases in response
rates. Interestingly, nicotine did have rate increasing and quarter-life effects, but the
doses tested which had a behavioral effect (.17, .30, .56 and 1.0 mg/kg, s.c.) affected
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control animals and caffeine-treated animals similarly, with no sensitization apparent
(Jaszyna et al, 1998).
Considering the range of behavioral effects engendered by caffeine
administration, of great applied concern may be the incidence of caffeine ingestion by
children. Caffeine is nearly ubiquitously self-administered by adults, so it follows reason
that it is also the psychoactive drug most readily self-administered by children, with
approximations of 77% regularly ingesting the drug (Tanda & Goldberg, 2000).
However, caffeine is also the most consumed psychotropic by pregnant and nursing
women. Although it is doubtful that teratogenic effects occur, caffeine readily passes
through the placenta and enters the fetal bloodstream, also passing into breast milk
(Julien, 2001). However from prenatal stages to at least 7 months of age, absent are the
enzymes necessary to demethylate the drug, causing a drug half-life anywhere from 32 to
149 hours (Parsons & Nemis, 1981), with 4 hours being average for an adult (James,
1991).
However, little experimental research that has been conducted with reference to
caffeine and children has yet to give way to any concern. When adolescents were given
choice trials between caffeinated and non-caffeinated soda pop (experiencing each
blindly prior to the trials), only 22% of the children (four of the eighteen) exhibited a
consistent choice with only one child meeting the researcher’s criteria for reliable
caffeine self-administration (Hale, Hughes, Oliveto & Higgins, 1995).  
Thus, chronic caffeine appears to generate multiple behavioral effects, both
clinical and in the laboratory, when combined with other stimulant drugs, consequently
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potentiating their reinforcing and discriminative stimulus effects, implicating the need for
a more detailed analysis of caffeine’s role in concomitant drug use and drug relapse.
Although displaying a large proportion of characteristics which typify compulsive
drug use, caffeine remains unregulated, presumably because of the absence of deleterious
consequences associated with its consumption. Even with inconsistent reports regarding
both the specific manner and extent of behavioral enhancement the drug affords, the
literature is nonetheless rich in reports of its ameliorative effects. When combining its
high therapeutic index, ease of availability and low cost with its ergogenic, attention
bolstering effects, it is subsequently dismissed as a psychotropic drug with abuse
potential and reassigned as a harmless if not helpful food additive. Not only is caffeine a
recreational agent which aids in augmented alertness, attenuating fatigue , mood assuage,
decreased reaction time and enhanced attentional focus, it also has properties of medical
utility. Caffeine is often administered to alleviate bronchial constriction (Henderson,
O'Connell & Fuller, 1993), ease headaches (Julien, 2001), prevent apnea in newborns
(McNamara, Nixon & Anderson, 2004) boost athletic performance without steroids and
alleviate symptoms of narcolepsy (Julien, 2001). Moreover, frequent caffeine
consumption is associated with increased metabolic efficacy, moderate weight loss and
decreased risk of type II diabetes (Greenberg, Axen, Schnoll & Boozer, 2005).
 Therefore, the present experiment, employing self-administration techniques for
the behavioral analysis of caffeine’s effects, has provided some evidence for the agent’s
behavior maintaining effects in animals. However, it is the position of this paper that a
more detailed analysis is warranted to further parse out the relative role of the direct
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effects of the drug, the specific neurochemical correlates which allow for behavioral
maintenance and the associated conditioned stimuli paired with the drug’s presentation.
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FIGURES
Figure 1. Mean number of infusions self-administered per session as a function of dose
and response requirement. Asterisks signify a statistically significant difference from that
of vehicle (*p<.05; **p<.01). Error bars represent one standard error of the mean.
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Figure 2. The number of caffeine infusions self-administered across sessions, with each
panel depicting one animals’ behavior.  Changes in schedule or dose conditions are
represented by a change in symbol and a break in the data.  Two of the four animals
experiencing these conditions are displayed.
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Figure 3. The number of caffeine infusions self-administered across sessions, with each
panel depicting one animals’ behavior.  Changes in schedule or dose conditions are
represented by a change in symbol and a break in the data.  Two of the four animals
experiencing these conditions are displayed.
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Figure 4. Mean pause duration per session as a function of dose availability and response
requirement. Asterisks signify a statistically significant difference from that of vehicle
(*p<.05; **p<.01). Error bars represent one standard error of the mean.
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Figure 5. Mean cumulative (mg) intake per session as a function of the dose available for
self-administration. Error bars represent one standard error of the mean.
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